Kisspeptin-10 Peptide USA | Buy Kisspeptin-10 5mg | Research-Grade HPG Axis Neuropeptide ≥99% Purity

Kisspeptin-10 (KP-10; Metastin 45–54) is a naturally occurring decapeptide — the conserved C-terminal active fragment shared by all members of the kisspeptin neuropeptide family encoded by the KISS1 gene — recognised as the most potent endogenous excitatory stimulus to hypothalamic GnRH neurons yet characterised in reproductive neuroendocrinology, and studied extensively across reproductive endocrinology, hypothalamic-pituitary-gonadal (HPG) axis biology, puberty and fertility research, KISS1R receptor pharmacology, steroid hormone feedback mechanisms, KNDy neuron biology, metabolic-reproductive coupling, psychosexual neuroscience, hypogonadotropic hypogonadism research, ovarian stimulation biology, and cancer metastasis suppression — making it one of the most biologically significant, clinically characterised, and actively researched neuropeptides in modern reproductive endocrinology and neuroendocrine systems biology, spanning from its original identity as a tumour metastasis suppressor to its current status as the defining upstream regulator of the entire hypothalamic-pituitary-gonadal reproductive axis. Researchers and institutions across the USA can source verified, research-grade Kisspeptin-10 5mg with fast domestic dispatch and full batch documentation included.

✅ ≥99% Purity — HPLC & Mass Spectrometry Verified

✅ Batch-Specific Certificate of Analysis (CoA) Included

✅ Sterile Lyophilised Powder | GMP Manufactured

✅ Fast Dispatch Across the USA | USA Peptides In Stock

What Is Kisspeptin-10?

Kisspeptin-10 (KP-10; also Metastin 45–54) is a biologically active decapeptide — a ten-amino acid peptide with the sequence Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ (YNWNSFGLRF-NH₂) — representing the conserved C-terminal active core that is shared identically across all four members of the kisspeptin peptide family: Kisspeptin-54, Kisspeptin-14, Kisspeptin-13, and Kisspeptin-10. All kisspeptin isoforms are derived by differential proteolytic processing from a single 145-amino acid precursor protein encoded by the KISS1 gene, located on the long arm of human chromosome 1 (1q32). The C-terminal decapeptide sequence of Kisspeptin-10 — which terminates in the Arg-Phe-NH₂ (RFamide) motif conserved across the broader RFamide neuropeptide superfamily — constitutes the minimum sequence required for high-affinity KISS1R binding and full biological activity, with radioligand competition studies confirming Ki values of 1.59 nM and 2.33 nM at rat and human KISS1R respectively, establishing Kisspeptin-10 as the most potent and compact kisspeptin fragment and the preferred research tool for KISS1R pharmacology studies.

Kisspeptin-10 exerts its biological effects exclusively through KISS1R (also historically designated GPR54) — a class A GPCR classified on chromosome 19p13 in humans, comprising 398 amino acids, and coupling predominantly to the Gq/11 pathway. Upon Kisspeptin-10 binding, KISS1R activates phospholipase C, generating IP3 and diacylglycerol, mobilising intracellular calcium stores, releasing arachidonic acid, and activating ERK1/2 and p38 MAP kinase cascades — a signal transduction profile that, in GnRH neurons of the hypothalamus, triggers membrane depolarisation through multiple cation channel types, driving the dramatic and prolonged pulsatile release of GnRH that initiates the entire downstream reproductive axis. Cryo-EM structural studies have further resolved that KISS1R can additionally couple to the Gi/o pathway, adding mechanistic complexity to the receptor’s signalling profile that is of ongoing research significance for KISS1R structural pharmacology.

The KISS1 gene was first isolated in 1996 by Danny Welch’s laboratory in Hershey, Pennsylvania — with the name KISS1 derived from the city’s association with Hershey’s Kisses chocolates — during a screen for metastasis suppressor genes in human melanoma, where introduction of chromosome 6 into metastatic melanoma cells suppressed metastatic potential and the responsible cDNA was identified as KISS1. The encoded peptide product was subsequently named metastin to reflect this function. The receptor GPR54 was independently identified in 1999 and its human orthologue isolated in 2001, at which point multiple groups simultaneously characterised kisspeptin as GPR54’s endogenous ligand — a discovery that rapidly shifted the field when loss-of-function mutations in human GPR54/KISS1R were shown in 2003 to cause isolated hypogonadotropic hypogonadism characterised by failure of pubertal development, definitively establishing kisspeptin/KISS1R signalling as an absolute requirement for the onset and maintenance of reproductive function in mammals.

KISS1R is expressed most prominently on GnRH neurons in the hypothalamus — specifically in the median eminence — and is also expressed in the pituitary, placenta, pancreas, liver, small intestine, adipose tissue, hippocampus, and ovarian and testicular tissues including Leydig cells, seminiferous tubules, and spermatids. This breadth of tissue expression reflects the expanding understanding of kisspeptin biology beyond the HPG axis and into metabolic, psychosexual, and peripheral reproductive tissue research contexts.

The principal hypothalamic kisspeptin-producing neuronal populations are the KNDy neurons — archetypally named for their co-expression of Kisspeptin, Neurokinin B, and Dynorphin — residing in the arcuate nucleus (ARC) and the anteroventral periventricular nucleus / rostral periventricular area of the third ventricle (AVPV/RP3V). KNDy neurons project directly to GnRH neurons and function as the pulse-generator circuit for GnRH secretion: neurokinin B activates KNDy neurons via NK3R auto-stimulation, driving kisspeptin release onto GnRH neurons; dynorphin terminates the pulse via κ-opioid receptor-mediated inhibition. KNDy neurons in the ARC express sex steroid receptors and are directly regulated by negative gonadal steroid feedback, while AVPV/RP3V kisspeptin neurons mediate the positive estrogen feedback responsible for the preovulatory LH surge in females — establishing the dual kisspeptin population as the central neural circuit integrating gonadal steroid feedback, metabolic status, and circadian and stress inputs to generate appropriate reproductive hormone pulsatility.

As the most potent endogenous KISS1R agonist, the most compact and research-tractable kisspeptin isoform, and a compound with a uniquely rich dual biological identity spanning metastasis suppression and reproductive neuroendocrinology, Kisspeptin-10 5mg research vials are in active demand across reproductive endocrinology, HPG axis pharmacology, fertility research, puberty biology, metabolic-reproductive coupling, psychosexual neuroscience, and cancer biology programs at research institutions nationwide.

What Does Kisspeptin-10 Do in Research?

In controlled pre-clinical and laboratory settings, Kisspeptin-10 has been studied across an exceptionally wide range of reproductive endocrine, neurobiological, metabolic, oncological, and psychosexual research applications:

KISS1R Receptor Pharmacology Research Kisspeptin-10’s primary research application is as the minimal endogenous reference ligand for KISS1R — used in receptor binding assays, Gq/11-PLC-IP3-calcium signalling characterisation, ERK1/2 and p38 kinase activation studies, receptor distribution mapping, and KISS1R pharmacology research. Studies have characterised Kisspeptin-10’s binding kinetics at rat and human KISS1R — establishing Ki values of 1.59 nM and 2.33 nM respectively — and cryo-EM structural studies have mapped the molecular determinants of KISS1R ligand recognition and G protein coupling selectivity using kisspeptin isoforms. Kisspeptin-10’s equivalence in efficacy and affinity to Kisspeptin-54 at KISS1R, combined with its compact ten-residue size, makes it the preferred reference compound for KISS1R pharmacology research over longer kisspeptin isoforms.

HPG Axis Activation and GnRH Pulse Biology Research Kisspeptin-10 is the most extensively studied upstream activator of the HPG axis in neuroendocrine research — with pre-clinical studies in rodents and primates documenting that central and peripheral Kisspeptin-10 administration produces robust, dose-dependent increases in GnRH release, LH, FSH, and downstream gonadal steroid secretion (testosterone and estrogen), effects that are blocked by concurrent GnRH receptor antagonist treatment, confirming the GnRH neuron as the obligatory intermediary. Studies have documented that Kisspeptin-10 stimulates over 85% of GnRH neurons in the hypothalamus and that its effects on LH secretion are reproducible across species from rodents to non-human primates to humans, establishing its HPG axis activation profile as one of the most translationally characterised of any research neuropeptide.

KNDy Neuron and GnRH Pulse Generator Research Research examining the cellular neurobiology of GnRH pulsatility has used Kisspeptin-10 extensively as a pharmacological probe of KNDy neuron function — with studies characterising how kisspeptin release from ARC KNDy neurons drives GnRH pulse initiation, how neurokinin B (NKB)/NK3R auto-excitation of KNDy neurons controls kisspeptin release timing, and how dynorphin/κ-opioid receptor inhibition of KNDy neurons terminates GnRH pulses. Research has established the dual-population architecture of the hypothalamic kisspeptin system — ARC KNDy neurons as the pulse generator and AVPV/RP3V neurons as the positive-feedback surge generator — and has used Kisspeptin-10 to probe the pharmacological accessibility of these distinct neuronal populations in the context of reproductive axis regulation.

Puberty Biology and Precocious/Delayed Puberty Research Kisspeptin-10 is a central research tool in puberty neuroendocrinology — with studies documenting that intermittent Kisspeptin-10 administration to pre-pubertal animals activates the hypothalamic-pituitary axis and induces precocious puberty in rodents and primates, while loss-of-function mutations in KISS1 or KISS1R produce a phenotype of complete pubertal failure and hypogonadotropic hypogonadism. Research in pre-pubertal dairy heifers has confirmed Kisspeptin-10’s capacity to increase plasma GH and LH, and studies across species have examined how KISS1R expression levels, hypothalamic kisspeptin neuron activation thresholds, and gonadal steroid feedback sensitivity change across the juvenile-to-pubertal developmental transition — with Kisspeptin-10 serving as the pharmacological interrogation tool for these mechanisms.

Hypogonadotropic Hypogonadism and Fertility Research Research has established Kisspeptin-10 as a research-characterised tool for interrogating hypogonadotropic hypogonadism (IHH/HH) biology — with clinical studies documenting that intravenous Kisspeptin-10 administration evokes two-to-fivefold increases in LH secretion in men with hypogonadotropic hypogonadism and type 2 diabetes, with 50% increases in LH pulse frequency and 35% increases in serum testosterone, and that continuous infusion in women with chronic amenorrhea induces robust LH and FSH increases. Pre-clinical studies in hyperprolactinemia-induced hypogonadotropic hypogonadism models have documented that daily Kisspeptin-10 restores gonadotropin secretion and menstrual cyclicity in mice, establishing the mechanistic rationale for kisspeptin-based approaches to fertility restoration. The capacity of Kisspeptin-10 to stimulate the reproductive axis at the level above GnRH — more physiologically upstream than either direct GnRH administration or exogenous gonadotropin treatment — establishes it as a research tool for examining more physiologically authentic reproductive axis activation patterns.

Gonadal Steroid Feedback Mechanism Research A mechanistically pivotal application of Kisspeptin-10 in reproductive endocrinology research is the investigation of steroid hormone feedback dynamics — particularly the differential regulation of the two hypothalamic kisspeptin populations. Studies have established that gonadal steroid negative feedback in the ARC and positive feedback in the AVPV are mediated through direct actions on sex steroid receptor-expressing KNDy neurons, with Kiss1 mRNA in the ARC increasing after gonadectomy and decreasing after sex steroid replacement, while the opposite occurs in the AVPV. Kisspeptin-10 has been used as a pharmacological probe to interrogate how these two feedback-sensitive populations contribute to tonic GnRH pulsatility versus the preovulatory LH surge, and to characterise the sex steroid concentrations and receptor subtypes (ERα, AR) mediating each feedback mode.

Ovarian Stimulation and IVF Biology Research Research examining the use of Kisspeptin-10 as an ovulation trigger in assisted reproduction biology has documented its capacity to induce a robust and self-limiting LH surge for oocyte maturation — a mechanism based on its natural role in triggering the preovulatory GnRH/LH surge — that is potentially advantageous over hCG-based ovulation triggers due to a theoretically lower risk of ovarian hyperstimulation syndrome (OHSS). Clinical and pre-clinical research has examined the LH surge dynamics, oocyte maturation outcomes, and hormonal profiles following Kisspeptin-10 administration in IVF protocols, and has compared its performance directly with GnRH agonist and hCG triggers — establishing ovarian stimulation biology as one of the most clinically relevant and actively investigated translational research dimensions of Kisspeptin-10 biology.

Psychosexual Neuroscience and Sexual Behaviour Research Research has examined Kisspeptin-10’s influence on psychosexual function and behaviour — with clinical studies in men with hypoactive sexual desire disorder (HSDD) documenting that Kisspeptin-10 administration significantly modulated brain activity in key sexual processing centres and increased physiological sexual arousal, including penile tumescence, in response to sexual stimuli. Parallel studies in women with HSDD have documented kisspeptin-dependent improvements in sexual brain responses. These findings implicate kisspeptin signalling in the neural circuit integration of reproductive hormone status and psychosexual arousal, extending Kisspeptin-10’s research relevance from hypothalamic neuroendocrinology into limbic and cortical sexual neuroscience. KISS1R expression in extrahypothalamic regions including the amygdala, hippocampus, and bed nucleus of the stria terminalis is consistent with a broader role in emotional-sexual behaviour integration beyond HPG axis activation.

Metabolic-Reproductive Coupling and Energy Balance Research Research has established that kisspeptin neurons are sensitive to metabolic and energy status — with studies documenting that both severe undernutrition and overnutrition attenuate kisspeptin’s stimulatory effect on GnRH release, contributing to the well-characterised suppression of reproductive function in metabolic extremes. Studies in Kiss1r-knockout mice have documented increased adiposity, reduced energy expenditure, and reduced locomotor activity — with KISS1R expression confirmed in adipose tissue and brown adipose tissue — establishing that kisspeptin-KISS1R signalling influences energy homeostasis as well as reproductive function. Research has further documented Kisspeptin-10’s influence on glucose homeostasis, insulin secretion, and body composition parameters in pre-clinical models, and has explored how leptin, ghrelin, and other metabolic signals interface with hypothalamic kisspeptin neuronal activity to coordinate reproductive readiness with nutritional status.

Hippocampal Synaptic Plasticity Research Research has examined Kisspeptin-10’s role in hippocampal synaptic biology — with studies confirming KISS1R expression in granule cells of the dentate gyrus, and electrophysiological experiments demonstrating that Kisspeptin-10 application produces rapid and substantial increases in the amplitude of excitatory synaptic responses without altering membrane properties — a postsynaptic potentiation effect mediated by ERK1/2, tyrosine kinase, and CaMKII signalling that is consistent with changes in AMPA receptor number or conductance. Kiss1 mRNA in the dentate gyrus is upregulated by seizure activity and enhanced neuronal excitability, suggesting autocrine kisspeptin actions in the hippocampus distinct from its hypothalamic reproductive endocrine roles, and establishing hippocampal synaptic plasticity as a non-reproductive research application with potential relevance to learning, memory, and seizure biology.

Hypogonadism Diagnostic Research Clinical research has explored Kisspeptin-10 as a diagnostic tool for differentiating constitutional delay of puberty from permanent hypogonadotropic hypogonadism — with studies examining LH response profiles following Kisspeptin-10 challenge as a means to assess the functional integrity of the KISS1R–GnRH neuron pathway. Patients with permanent HH show characteristically attenuated LH responses to Kisspeptin-10 challenge compared to those with functional delay, reflecting the biological principle that a functionally intact KISS1R–GnRH neuron axis is required for a normal kisspeptin-evoked LH response — establishing kisspeptin challenge pharmacology as a diagnostically relevant research paradigm in HH biology.

Tumour Metastasis Suppression and Cancer Biology Research Kisspeptin-10 retains the metastasis-suppressive biology of its parent KISS1 gene product — with studies documenting that Kisspeptin-10 inhibits cancer cell invasion and metastatic potential in mouse melanoma models, suppresses SDF-1-induced CXCR4 signalling and chemotaxis (a pathway implicated in directing metastatic cell migration), and that KISS1R activation can promote cell cycle arrest and apoptosis in human tumour cell lines through a specific transcriptional programme not shared by other Gq-coupled receptors. Research has examined KISS1R expression across cancer types including breast, melanoma, gastric, and ovarian cancers — where reduced KISS1R expression correlates with more advanced disease and greater metastatic potential — establishing cancer metastasis biology as a parallel and historically foundational research domain of the kisspeptin field.

All applications are for research purposes only. Kisspeptin-10 as supplied is not intended for human therapeutic use.

What Do Studies Say About Kisspeptin-10?

Kisspeptin-10 has accumulated one of the most clinically and mechanistically characterised research profiles of any neuropeptide in reproductive endocrinology:

HPG Axis Activation: Studies across species — from rodents to non-human primates to humans — have established Kisspeptin-10 as a potent, GnRH-dependent activator of the HPG axis, with clinical research documenting dose-dependent LH increases following intravenous administration and continuous infusion producing sustained LH, FSH, and testosterone elevation. The reproductive axis responses to Kisspeptin-10 are among the most rigorously characterised for any neuropeptide in translational neuroendocrinology.

Reproductive Disorders: Clinical studies have documented that Kisspeptin-10 restores gonadotropin secretion in models of IHH and amenorrhea — including robust LH and FSH responses in women with chronic amenorrhea and men with HH and type 2 diabetes — providing proof-of-concept data for kisspeptin-based approaches to HPG axis interrogation and establishing Kisspeptin-10 as a pharmacologically validated tool for studying reproductive axis hypoactivation biology.

KNDy Neuron Biology: Pre-clinical research has comprehensively mapped the KNDy neuron circuit — with studies establishing ARC KNDy neurons as the GnRH pulse generator, characterising the NKB/NK3R positive autocrine loop and dynorphin/KOR negative feedback that controls pulse termination, and documenting how sex steroid feedback directly regulates kisspeptin mRNA expression in a nucleus-specific, feedback-direction-specific manner. These studies have established the most detailed mechanistic model for GnRH pulse generator control available in reproductive neuroendocrinology.

Puberty Biology: Research has confirmed that kisspeptin-KISS1R signalling is an absolute genetic and physiological requirement for pubertal onset in mammals — with loss-of-function mutations in KISS1 and KISS1R causing complete pubertal failure in both mice and humans, and activating KISS1R mutations causing precocious puberty. These human genetic findings provide the most compelling translational validation of KISS1R’s role in reproductive development.

Psychosexual Biology: Clinical studies have documented kisspeptin’s modulation of sexual brain responses and physiological arousal in men and women with hypoactive sexual desire disorder — extending kisspeptin’s research significance from hypothalamic neuroendocrinology into the neural integration of reproductive hormone signals and psychosexual behaviour, and positioning Kisspeptin-10 as a pharmacological probe for the neuroscience of sexual motivation.

Metabolic Biology: Research has established that kisspeptin neurons are direct sensors of metabolic status that link energy availability to reproductive axis activation — with Kiss1r-knockout studies confirming bidirectional metabolic phenotypes including increased adiposity and reduced energy expenditure, and mechanistic research identifying KISS1R in adipose and metabolic tissues as components of a broader homeostatic network coordinating reproduction with energy balance.

Cancer Metastasis Suppression: Studies have confirmed Kisspeptin-10’s inhibitory effects on cancer cell invasion and CXCR4-mediated metastatic signalling — with KISS1R expression analyses across tumour types confirming inverse correlations between receptor expression and metastatic potential, establishing the kisspeptin-KISS1R axis as a mechanistically credible and research-active component of metastasis suppression biology.

Kisspeptin-10 vs Related Reproductive Endocrine and Neuropeptide Research Compounds

Feature	Kisspeptin-10	GnRH	Oxytocin	Neurokinin B
Type	KISS1 gene-derived decapeptide / RFamide family	Hypothalamic decapeptide releasing hormone	Hypothalamic cyclic nonapeptide neurohormone	Tachykinin neuropeptide (undecapeptide)
Primary Receptor	KISS1R / GPR54 (Gq/11 GPCR)	GnRHR (Gq/11 GPCR)	OXTR (Gq/11 GPCR)	NK3R / TACR3 (Gq/11 GPCR)
Position in HPG Axis	Upstream of GnRH neurons — the HPG axis activator	Central HPG node — pituitary gonadotropin release signal	Hypothalamic neurohormone — HPG-adjacent but primarily social/reproductive tissue roles	KNDy neuron autoactivator — kisspeptin pulse trigger
Primary Research Focus	HPG axis activation / KISS1R pharmacology / puberty and fertility / KNDy neuron biology / metastasis suppression	GnRH receptor pharmacology / gonadotropin biology / HPG axis reference	Social bonding / uterine and mammary biology / stress / oxytocin receptor pharmacology	KNDy pulse generator biology / menopausal VMS research / NK3R pharmacology
Key Research Distinction	Most potent endogenous GnRH stimulator — upstream physiological lever for the entire HPG axis; dual identity as metastasis suppressor	Central HPG effector — not upstream pulse biology; direct pituitary-level research	Primarily social and peripheral reproductive — not HPG axis upstream activation	Intra-KNDy autocrine — pulse timing regulation rather than downstream HPG activation
Best For	KISS1R pharmacology / HPG pulse biology / puberty and fertility / IVF research / HH diagnosis / cancer metastasis research	GnRHR pharmacology / pituitary gonadotropin biology / reproductive endocrinology	OXTR pharmacology / social neuroscience / reproductive tissue biology / stress research	KNDy neuron physiology / NK3R pharmacology / menopausal hot flush biology

Product Specifications

Parameter	Specification
Full Name	Kisspeptin-10 (KP-10; Metastin 45–54)
Sequence	H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ (YNWNSFGLRF-NH₂)
CAS Number	374683-27-9
Molecular Formula	C₆₃H₈₃N₁₇O₁₄
Molecular Weight	~1,302.4 Da
Peptide Length	10 Amino Acids (Decapeptide) — linear, C-terminal amide
C-Terminal Motif	Arg-Phe-NH₂ (RFamide) — essential for KISS1R recognition
Gene Origin	KISS1 gene (chromosome 1q32) — C-terminal decapeptide of 145AA precursor
Type	Endogenous neuropeptide / RFamide superfamily
Isoform Context	Minimal active sequence shared by KP-54, KP-14, KP-13, and KP-10
Primary Receptor	KISS1R / GPR54 — class A GPCR (Gq/11 and Gi/o coupling)
KISS1R Binding Affinity	Ki = 1.59 nM (rat); 2.33 nM (human)
Downstream Signalling	PLC → IP3 + DAG → intracellular Ca²⁺ mobilisation; arachidonic acid release; ERK1/2 and p38 MAPK phosphorylation
Primary Biological Role	Upstream HPG axis activator — stimulates GnRH neuronal depolarisation and pulsatile GnRH release
Vial Size	5mg
Purity	≥99% (HPLC & MS Verified)
Form	Sterile Lyophilised Powder
Solubility	Sterile water, bacteriostatic water, PBS, 0.1% BSA-containing buffer (for low concentrations)
Storage (Powder)	-20°C, protect from light and moisture
Storage (Reconstituted)	2–8°C, use within 28 days with bacteriostatic water
Manufacturing	GMP Manufactured

Buy Kisspeptin-10 5mg in the USA — What’s Included

Every order includes full batch documentation:

✅ Batch-Specific Certificate of Analysis (CoA)

✅ HPLC Chromatogram

✅ Mass Spectrometry Confirmation

✅ Sterility & Endotoxin Testing Report

✅ Reconstitution Protocol

✅ Technical Research Support

Frequently Asked Questions — Kisspeptin-10 USA

Can I buy research-grade Kisspeptin-10 in the USA? Yes. We supply research-grade Kisspeptin-10 5mg to researchers and institutions across the United States. All orders include full batch documentation and are packaged to maintain peptide integrity during transit. This compound is supplied strictly for laboratory research use only.

Why is Kisspeptin-10 considered the preferred research isoform over Kisspeptin-54? Kisspeptin-10 represents the conserved ten-amino acid C-terminal sequence shared identically across all kisspeptin isoforms — and radioligand binding studies have established that it binds KISS1R with equivalent affinity and produces equivalent maximal biological responses to the much larger Kisspeptin-54 (54 amino acids). This pharmacological equivalence at KISS1R, combined with Kisspeptin-10’s substantially smaller size (MW ~1,302 Da versus ~6,800 Da for KP-54), makes it significantly easier to synthesise at research grade, more cost-effective to produce at high purity, more tractable for dosing calculations in in vitro assays, and better suited to mechanistic receptor pharmacology studies where the minimal active sequence is desirable. Kisspeptin-54’s N-terminal extension beyond the conserved decapeptide does not contribute to KISS1R binding affinity, making it biologically redundant for most KISS1R pharmacology research contexts. For this reason, Kisspeptin-10 has become the standard isoform for both laboratory KISS1R research and clinical pharmacological studies.

What is the significance of the RFamide motif in Kisspeptin-10? The Arg-Phe-NH₂ (RFamide) motif at the C-terminus of Kisspeptin-10 — corresponding to residues 9 and 10 of the decapeptide, with the phenylalanine C-terminally amidated — is a structurally critical pharmacophore for KISS1R binding. Kisspeptin belongs to the broader RFamide neuropeptide superfamily, whose members all terminate in the same Arg-Phe-NH₂ motif and include neuropeptides with diverse biological roles in reproduction, pain modulation, appetite, and circadian biology. The RFamide motif is essential for Kisspeptin-10’s receptor recognition: peptide analogues with C-terminal amide deletion or modification show dramatically reduced KISS1R binding affinity and biological activity. This makes C-terminal amide integrity a critical quality parameter for research-grade Kisspeptin-10 — and mass spectrometry confirmation of the correct molecular weight including the amidated C-terminus is an important component of batch quality documentation.

What is the KNDy neuron model and why is it important for Kisspeptin-10 research? The KNDy neuron model describes a population of arcuate nucleus hypothalamic neurons that co-express Kisspeptin, Neurokinin B (NKB), and Dynorphin and function as the endogenous GnRH pulse generator. The current working model of GnRH pulsatility proposes that NKB released from KNDy neurons activates neighbouring KNDy neurons via NK3R auto-stimulation — a positive feedback loop that amplifies kisspeptin release onto GnRH neurons and initiates a GnRH pulse. Dynorphin then acts via κ-opioid receptors (KOR) on KNDy neurons to terminate the pulse, producing the characteristic intermittent, clock-like pattern of GnRH secretion that drives pulsatile LH release from the anterior pituitary. A second kisspeptin neuronal population in the AVPV/RP3V generates the preovulatory positive-estrogen-feedback LH surge through a distinct mechanism. The KNDy model is of fundamental importance for Kisspeptin-10 research because it provides the mechanistic framework for understanding how kisspeptin integrates multiple endocrine signals — gonadal steroids, metabolic hormones, circadian signals, stress inputs — into coordinated reproductive axis output, making Kisspeptin-10 the pharmacological probe of choice for interrogating this pulse generator circuit.

How does Kisspeptin-10 relate to menopausal vasomotor symptoms (VMS) research? Menopausal hot flushes and vasomotor symptoms (VMS) are mechanistically linked to hyperactivation of ARC KNDy neurons following the withdrawal of gonadal steroids at menopause — with oestrogen-deficient KNDy neurons becoming markedly hyperactive, projecting to the thermoregulatory median preoptic nucleus (MnPO), and generating the aberrant thermosensory signals that produce hot flushes. This has established KNDy neuron biology as the mechanistic basis of menopausal VMS, with neurokinin B/NK3R signalling — the autocrine activator of KNDy neurons — emerging as a therapeutic target, and kisspeptin as the downstream output peptide of the same neurons. Kisspeptin-10 is a valuable research tool for examining KNDy neuron biology in this context — probing how kisspeptin signalling and NK3R pathway activity in menopausal-state neuronal models contribute to thermoregulatory dysregulation, and informing the mechanistic understanding that has driven the development of NK3R antagonists for menopausal VMS treatment.

What purity is required for Kisspeptin-10 research? ≥98% is considered research-grade, but ≥99% purity is strongly preferred for KISS1R radioligand binding assays, GnRH neuron activation studies, HPG axis pharmacology experiments, KNDy neuron biology research, IVF ovulation trigger studies, and clinical translational research where peptide purity directly affects KISS1R binding fidelity, GnRH release kinetics, and experimental reproducibility. Correct C-terminal amidation — confirmed by mass spectrometry — is an equally critical quality parameter alongside purity percentage. All Kisspeptin-10 supplied for USA researchers is independently verified to ≥99% with mass spectrometry confirmation of the correct amidated molecular weight.

How is Kisspeptin-10 reconstituted for lab use? Allow the vial to reach room temperature before opening. Add sterile water, bacteriostatic water, or PBS slowly down the vial wall and swirl gently — do not shake vigorously. Kisspeptin-10 is a linear decapeptide with good aqueous solubility under physiological buffer conditions. For low-concentration working solutions intended for cell-based assays, addition of a protein carrier such as 0.1% BSA can reduce non-specific adsorption to plasticware surfaces. Stock solutions should be prepared at higher concentrations (e.g., 1 mM in PBS) and diluted to working concentrations immediately before use. For multi-use protocols, bacteriostatic water extends the usable life of reconstituted solution to 28 days when stored at 2–8°C. For long-term storage of working solutions, aliquot and store at -80°C to preserve Kisspeptin-10’s KISS1R binding activity and RFamide motif integrity. Avoid repeated freeze-thaw cycles and protect from light and oxidative conditions to maintain the tryptophan and tyrosine residues that contribute to the UV absorbance profile used in HPLC quality verification.

Research Disclaimer

Kisspeptin-10 is supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic application. It must be handled by qualified researchers in compliance with applicable US federal and state regulations and institutional ethics guidelines. By purchasing, you confirm that this compound will be used solely for approved in-vitro or pre-clinical research purposes.